0
Seelos Therapeutics, Inc. Banner Image

Seelos Therapeutics, Inc.

  • Ticker SEEL
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Seelos Therapeutics, Inc. Logo Image
  • 1-10 Employees
  • Based in New York City, New York
Seelos Therapeutics, Inc. is a clinical-stage bio-pharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and in rare diseases. The Company’s portfolio includes several late-stage clinical assets targeting psychiatric and movement disorders, including orphanMore diseases. Seelos is based in New York, New York. Seelos’ common stock is traded on The Nasdaq Capital Market under the symbol "SEEL"​.
REPORT RATINGS
4.8 / 5.0 (268)

Seelos Therapeutics, Inc. reports have an aggregate usefulness score of 4.8 based on 268 reviews.

Seelos Therapeutics, Inc.

Most Recent Annual Report

Seelos Therapeutics, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Seelos Therapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!